Ahngook Pharma

Ahngook Pharma is a leading South Korean pharmaceutical company founded in 1955, dedicated to improving human health through the development of innovative and high-quality medicines. The company has established a strong market presence in respiratory, gastrointestinal, and circulatory therapeutic areas, notably through its flagship natural cough suppressant, Synatura. Beyond its robust portfolio of generic and licensed products, Ahngook is aggressively expanding its R&D pipeline to include biosimilars, improved molecular entities, and novel small molecules. Key development programs focus on high-growth areas such as ophthalmology, specifically wet age-related macular degeneration, and metabolic disorders like diabetes. With a state-of-the-art manufacturing facility in Hwaseong and a dedicated central research institute, the company is well-positioned for international expansion and strategic global partnerships. Ahngook Pharma is publicly traded on the KOSDAQ exchange and continues to transition toward becoming a research-driven global biopharmaceutical player.